Pinedo HM - Search Results

1

Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780.

Ruiz van Haperen VW, Veerman G, Eriksson S, Boven E, Stegmann AP, Hermsen M, Vermorken JB, Pinedo HM, Peters GJ. Ruiz van Haperen VW, et al. Among authors: pinedo hm. Cancer Res. 1994 Aug 1;54(15):4138-43. Cancer Res. 1994. PMID: 8033147

2

Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity.

Kroep JR, Loves WJ, van der Wilt CL, Alvarez E, Talianidis I, Boven E, Braakhuis BJ, van Groeningen CJ, Pinedo HM, Peters GJ. Kroep JR, et al. Among authors: pinedo hm. Mol Cancer Ther. 2002 Apr;1(6):371-6. Mol Cancer Ther. 2002. PMID: 12477049

3

Determinants of resistance to 2',2'-difluorodeoxycytidine (gemcitabine).

Bergman AM, Pinedo HM, Peters GJ. Bergman AM, et al. Among authors: pinedo hm. Drug Resist Updat. 2002 Feb;5(1):19-33. doi: 10.1016/s1368-7646(02)00002-x. Drug Resist Updat. 2002. PMID: 12127861 Review.

4

Human ovarian cancer xenografts in nude mice: characterization and analysis of antigen expression.

Molthoff CF, Calame JJ, Pinedo HM, Boven E. Molthoff CF, et al. Among authors: pinedo hm. Int J Cancer. 1991 Jan 2;47(1):72-9. doi: 10.1002/ijc.2910470114. Int J Cancer. 1991. PMID: 1985883

5

Doxorubicin compared with related compounds in a nude mouse model for human ovarian cancer.

Boven E, Schlüper HM, Erkelens CA, Pinedo HM. Boven E, et al. Among authors: pinedo hm. Eur J Cancer. 1990;26(9):983-6. doi: 10.1016/0277-5379(90)90626-5. Eur J Cancer. 1990. PMID: 2149026

6

Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.

Westerhof GR, Rijnboutt S, Schornagel JH, Pinedo HM, Peters GJ, Jansen G. Westerhof GR, et al. Among authors: pinedo hm. Cancer Res. 1995 Sep 1;55(17):3795-802. Cancer Res. 1995. PMID: 7641196

7

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer.

Boven E, Schipper H, Erkelens CA, Hatty SA, Pinedo HM. Boven E, et al. Among authors: pinedo hm. Br J Cancer. 1993 Jul;68(1):52-6. doi: 10.1038/bjc.1993.285. Br J Cancer. 1993. PMID: 8318420 Free PMC article.

8

Regulation of phosphorylation of deoxycytidine and 2',2'-difluorodeoxycytidine (gemcitabine); effects of cytidine 5'-triphosphate and uridine 5'-triphosphate in relation to chemosensitivity for 2',2'-difluorodeoxycytidine.

van Haperen VW, Veerman G, Vermorken JB, Pinedo HM, Peters G. van Haperen VW, et al. Among authors: pinedo hm. Biochem Pharmacol. 1996 Apr 12;51(7):911-8. doi: 10.1016/0006-2952(95)02402-6. Biochem Pharmacol. 1996. PMID: 8651941

9

Antitumor activity of prolonged as compared with bolus administration of 2',2'-difluorodeoxycytidine in vivo against murine colon tumors.

Veerman G, Ruiz van Haperen VW, Vermorken JB, Noordhuis P, Braakhuis BJ, Pinedo HM, Peters GJ. Veerman G, et al. Among authors: pinedo hm. Cancer Chemother Pharmacol. 1996;38(4):335-42. doi: 10.1007/s002800050492. Cancer Chemother Pharmacol. 1996. PMID: 8674156

10

Anti-tumor activity of CPT-11 in experimental human ovarian cancer and human soft-tissue sarcoma.

Jansen WJ, Kolfschoten GM, Erkelens CA, Van Ark-Otte J, Pinedo HM, Boven E. Jansen WJ, et al. Among authors: pinedo hm. Int J Cancer. 1997 Dec 10;73(6):891-6. doi: 10.1002/(sici)1097-0215(19971210)73:6<891::aid-ijc22>3.0.co;2-6. Int J Cancer. 1997. PMID: 9399672

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

697 results

Search Page

Filters